Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Bed Bath & Beyond To Provide Investor Update At 8:15 a.m. ET

Events
News

Bed Bath & Beyond To Provide Investor Update At 8:15 a.m. ET

https://edge.media-server.com/mmc/p/dach99xb

byBill Haddad

August 31, 2022

1 minute read

https://edge.media-server.com/mmc/p/dach99xb

Ford, GM May Take A Leaf from Elon Musk’s Tesla Playbook For Success: Fewer Options, More Profit

By Benzinga Neuro

August 17, 7:17 AM

Legacy automakers may reduce customization options, taking cues from Tesla and Chinese EV firms, reports Business Insider. American…

Gannett Q3 GAAP EPS $(0.39) Versus $0.09 Prior Year, Sales $717.90M Miss $745.50M Estimate

By Benzinga Newsdesk

November 3, 7:05 AM

Gannett (NYSE:GCI) reported quarterly losses of $(0.39) per share versus $0.09 in the same period last year. The company reported quarterly sales of $717.90 million which missed the analyst consensus estimate of $745.50

GCI

AstraZeneca’s COVID-19 Treatment Allowed In China’s Southern City: Reuters

By Vandana Singh

July 6, 3:06 PM

AstraZeneca Plc’s (NASDAQ:AZN) COVID-19 antibody cocktail has been cleared for use in a medical tourism zone in China’s southern…

AZN

SunCar Technology Group Inc. Announced Its Operational Results For FY22; FY22 EPS $(0.03) Vs $(0.11) YoY; Revenue $282.4M Vs $249.2M YoY

By Happy Mohamed

July 3, 12:30 PM

Full Year 2022 Financial Results Total revenues in the fiscal year of 2022 were $282.4 million, representing an increase of 13% from $249.2 million in the fiscal year of 2021. The

SDA

Bed Bath & Beyond To Provide Investor Update At 8:15 a.m. ET

Related Posts

Ford, GM May Take A Leaf from Elon Musk’s Tesla Playbook For Success: Fewer Options, More Profit

Gannett Q3 GAAP EPS $(0.39) Versus $0.09 Prior Year, Sales $717.90M Miss $745.50M Estimate

AstraZeneca’s COVID-19 Treatment Allowed In China’s Southern City: Reuters

SunCar Technology Group Inc. Announced Its Operational Results For FY22; FY22 EPS $(0.03) Vs $(0.11) YoY; Revenue $282.4M Vs $249.2M YoY